Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
Ankylosing Spondylitis (AS) is a common inflammatory rheumatic disease with a predilection for the axial skeleton, affecting 0.2% of the population. Current diagnostic criteria rely on a composite of clinical and radiological changes, with a mean time to diagnosis of 5 to 10 years. In this study we...
Main Authors: | Fischer, R, Trudgian, D, Wright, C, Thomas, G, Bradbury, L, Brown, M, Bowness, P, Kessler, B |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2012
|
Títulos similares
-
MASS SPECTROMETRY-BASED DETECTION AND QUANTITATION OF PUTATIVE BIOMARKERS FOR ANKYLOSING SPONDYLITIS
por: Fischer, R, et al.
Publicado: (2011) -
A proteomic approach to the identification of marker proteins for ankylosing spondylitis and rheumatoid arthritis
por: Wright, C, et al.
Publicado: (2005) -
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis
por: Mark Hwang, et al.
Publicado: (2023-04-01) -
Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.
por: Wright, C, et al.
Publicado: (2010) -
Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.
por: Wright, C, et al.
Publicado: (2012)